The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors
Who is this study for? Children and adults with Velocardiofacial Syndrome, Williams Syndrome, or Fragile X Syndrome
What treatments are being studied? Methylphenidate+Fluoxetin+Risperidone
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
The purpose of this study is to investigate the Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• chromosomal deletion proven by FISH examination
Locations
Other Locations
Israel
Schneider Children's Mediac Center of Israel
RECRUITING
Petah Tikva
Contact Information
Primary
Doron Gothelf, MD
gothelf@post.tau.ac.il
972-03-5302663
Time Frame
Start Date: 2001-05
Estimated Completion Date: 2024-08
Participants
Target number of participants: 400
Treatments
Experimental: 1
Related Therapeutic Areas
Sponsors
Leads: The Chaim Sheba Medical Center